Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AMGEN INC Director's Dealing 2024

May 10, 2024

29819_dirs_2024-05-09_bc57c675-729a-40aa-9678-14a22055a889.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMGEN INC (AMGN)
CIK: 0000318154
Period of Report: 2024-05-07

Reporting Person: Santos Esteban (EVP, Operations)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-05-07 Common Stock A 2997 $300.30 Acquired 71304 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-05-07 Nqso (Right to Buy) $300.30 A 19469 Acquired 2034-05-07 Common Stock (19469) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 856.6105 Indirect

Footnotes

F1: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 5/7/2026, 5/7/2027 and 5/7/2028, respectively.

F2: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,348 RSUs which will vest on 4/30/2025; 2,437 RSUs which will vest in installments of 1,200 on 5/2/2025, and 1,237 on 5/2/2026; 3,559 RSUs which will vest in two installments of 1,174 each on 5/2/2025 and 5/2/2026, and one installment of 1,211 on 5/2/2027; and 2,997 RSUs which will vest in two installments of 989 on 5/7/2026 and on 5/7/2027, and one installment of 1,019 on 5/7/2028. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

F3: These shares include 425 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

F4: These shares are acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing.

F5: These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/7/2026, 5/7/2027 and 5/7/2028, respectively.